Key result
Five-week LMWH prevents the delayed surge in haemostatic activation vs 1-week therapy after hip arthroplasty.
Why the study?
Tissue injury during total hip arthroplasty activates the haemostatic system, and the influence of prolonged thromboprophylaxis on haemostatic markers is unclear.
Does prolonged thromboprophylaxis with dalteparin for 5 weeks reduce postoperative activation of the haemostatic system compared to 1 week of dalteparin in patients undergoing total hip arthroplasty?
RCT
randomized
Yes
Does prolonged thromboprophylaxis with dalteparin for 5 weeks reduce postoperative activation of the haemostatic system compared to 1 week of dalteparin in patients undergoing total hip arthroplasty?
Prolonged thromboprophylaxis with dalteparin for 5 weeks significantly attenuates late postoperative activation of the haemostatic system compared to a standard 1-week regimen in patients undergoing total hip arthroplasty.
Answers are grounded in this paper and cite their sources.
May support extended LMWH after hip arthroplasty to blunt late activation; leaves open clinical VTE impact.
Tissue injury during hip surgery results in the activation of the haemostatic system. The aim of this study was to detect markers of haemostatic activity, i.e. prothrombin fragment 1 and 2 (F1+2), thrombin-antithrombin (TAT) complexes, fibrin degradation products (FbDP), and soluble fibrin monomers (SF), preoperatively, and on days 1, 7 and 35 in plasma of patients undergoing total hip arthroplasty. The study was part of a multicentre study in which the patients were randomized to receive a subcutaneous injection of low molecular weight heparin (LMWH, dalteparin, Fragmin) once daily for 5 weeks or placebo following a 1-week LMWH treatment (once daily). Bilateral phlebography was performed between days 33 and 35 or before if patients had clinical symptoms of deep vein thrombosis. A lung scan was performed in patients with clinical symptoms of pulmonary embolism. Levels of the markers were significantly increased on day 35 in the patients receiving LMWH for 7 days compared to patients receiving LMWH for 35 days. In patients receiving LMWH for 5 weeks, levels of FbDP and SF were significantly higher during the entire study period, but TAT and F1+2 were normalized on day 35. The markers were increased two to five times on the 1st postoperative day in patients with diagnosed venous thromboembolism.
No takes yet. Share an insight, caveat, or question.
Birthe Søgaard Andersen (2009) conducted an RCT in Total hip arthroplasty. Low molecular weight heparin (dalteparin) vs. 1-week LMWH followed by placebo was evaluated on Markers of haemostatic activity (F1+2, TAT, FbDP, SF). Prolonged thromboprophylaxis with LMWH for 5 weeks prevented the significant increase in haemostatic markers seen on day 35 in patients receiving only 1 week of LMWH after total hip arthroplasty.
Synapse has enriched 10 related papers. Consider them for comparative context: